The intelligent manufacturing headquarters of Dashenlin Medicine Group plans to settle in Chancheng District, Foshan, aiming to establish a modern national factory for the research and development of traditional Chinese medicine (TCM) herbal decoction pieces. With an estimated annual production capacity of 15,000 tons, the factory focuses on the development and production of high-quality TCM health products such as ginseng and antler extracts, premium soup ingredients, orally-taken herbal decoction pieces, and other new types of decoction pieces.

On September 12, Dashenlin Medicine Group signed a framework agreement for the Dashenlin Medicine Intelligent Manufacturing Headquarters Project with the government of Chancheng District at Foshan Guest Hotel. The project plans to establish a headquarters base for the intelligent manufacturing of TCM decoction pieces in Nanzhuang Town, Chancheng Distrtict.

"Dashenlin Group plans to establish a large-scale modern national factory for TCM decoction pieces in Foshan. With excellent industrial base and high standards, we will introduce advanced production and processing equipment to create an intelligent, standardized, and digitalized modern factory that meets GMP certification," said Ke Guoqiang, CEO of Dashenlin Medicine Group. "After the project is completed, together with the Lecong Logistics Supply Chain Base, Foshan will become the 'second headquarters' with the largest investment and greatest significance for Dashenlin, apart from the one in Guangzhou."

More importantly, the establishment of the manufacturing headquarters will provide strong support for the high-quality development of the pharmaceutical industry in Foshan, especially the development of the TCM industrial cluster. Going forward, Foshan will create a first-class business environment, provide optimal services, ensure the highest efficiency, and guarantee that the project will be completed on schedule and put into operation as soon as possible.

Reporter | Christy

Revisor | Eddie, Lynn

Photo | Foshan News and Media Center, Dashenlin Medicine Group